Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Administration of EBV-Specific Cytotoxic T Lymphocytes Following CD45 Antibody to Patients With EBV Positive Nasopharyngeal Carcinoma

NCT00078546 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT00078546
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00078546 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Administration of EBV-Specific Cytotoxic T Lymphocytes Following CD45 Antibody to Patients With EBV Positive Nasopharyngeal Carcinoma
Lead sponsor
Baylor College of Medicine
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2003
Completion date
April 30, 2007
Enrollment
12 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ebv infections, nasopharyngeal cancer